Antimycobacterial activity of the red alga Polysiphonia virgata

Pharmaceutical Biology

Volumn 46, Issue 4, 2008, Pages 254-260

  Saravanakumar, D E M ^a   Folb, P I ^b   Campbell, B W ^c   Smith, P ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antimycobacterial; Marine algae; Marine natural products; Mycobacterium tuberculosis; Polysiphonia virgata; Seaweeds; Tuberculosis

Indexed keywords

DICHLOROMETHANE; LAURIC ACID; LINOLEIC ACID; LONG CHAIN FATTY ACID; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PLANT EXTRACT; POLYSIPHONIA VIRGATA EXTRACT; STEARIC ACID; UNCLASSIFIED DRUG;

ANTIMYCOBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DRUG ACTIVITY; ENZYME ISOLATION; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYSIPHONIA VIRGATA; RADIOMETRY; RED ALGA;

ALGAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; POLYSIPHONIA VIRGATA; RHODOMELACEAE; RHODOPHYTA;

EID: 41349120268     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200701739413     Document Type: Article

References (48)

1. Ahn C, Jeon Y, Kang D, Shin T, Jung B (2004): Free radical scavenging activity of enzymatic extracts from a brown seaweed Scytosiphon lomentaria by electron spin resonance spectrometry. Food Res Int 37: 253-258.
2. Ahn M, Yoon K, Kim CY, Min S, Kim Y, Kim HJ, Kim JH, Shin C, Lee C, Kim TG, Kim SH, Huh H, Kim J (2002): Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts. J Appl Phycol 14: 325-329.
3. Benyagoub M, Rhlid RB, Bélanger RR (1996): Purification and characterization of new fatty acids with antibiotic activity produced by Sporothrix flocculosa. J Chem Ecol 22: 405-413.
4. Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens MJ, Cardellina JH II, Buckheit RW, Nara PL, Pannell LK, Sowder RC, Henderson LE (1997): Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp 120: Potential application to microbicide development. Antimicrob Agents Chemother 41: 1521-1530.
5. Caccamese S, Toscano RM, Furnari G, Cormaci M (1985): Antimicrobial activities of red and brown algae from southern Italy coast. Bot Mar 28: 505-507.
6. Carballeira NM (2002): New advances in the chemistry of methoxylated lipids. Prog Lipid Res 41: 437-456.
7. Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS, Damonte EB (1999): Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antiviral Res 43: 93-102.
8. Chevolot L, Foucault A, Chaubet F, Kervarec N, Sinquin C, Fisher A, Boisson-Vidal C (1999): Further data on the structure of brown seaweed fucans: Relationships with anticoagulant activity. Carbohydr Res 319: 154-165.
9. Chomcheon P, Wiyakrutta S, Sriubolmas N, Ngamrojanavanich N, Isarangkul D, Kittakoop P (2005): 3-Nitropropionic acid (3-NPA), a potent antimycobacterial agent from endophytic fungi: Is 3-NPA in some plants produced by endophytes? J Nat Prod 68: 1103-1105.
10. Critchley AT, Gillespie RD, Rotmann KWG (1998): Seaweed resources of South Africa. In: Critchley AT, Ohno M, eds. Seaweed Resources of the World. Yokosuka, Japan, Japan International Cooperation Agency, pp. 413-425.
11. Dembitsky VM, Srebnik M (2002): Natural halogenated fatty acids: Their analogues and derivatives. Prog Lipid Res 41: 315-367.
12. Donia M, Hamann MT (2003): Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis 3: 338-348.
13. Evans WC (1996): Hydrocarbons and derivatives. In: Trease and Evans' Pharmacognosy, London, WB Saunders, 14th edn, p. 172.
14. Findlay JA, Patil AD (1984): Antibacterial constituents of the diatom Navicula delognei. J Nat Prod 47: 815-818.
15. Fujiwara PI, Simone PM, Munsif SS (2000): Treatment of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis, a Comprehensive International Approach, 2nd ed., revised and expanded. New York, Marcel Dekker Inc., P. 401.
16. Haefner B (2003): Drugs from the deep: Marine natural products as drug candidates. Drug Discovery Today 8: 536-544.
17. Hiroishi S, Sugie K, Yoshida T, Morimoto J, Taniguchi Y, Imai S, Kurebayashi J (2001): Antitumour effects of Marginisporum crassissimum (Rhodophyceae), a marine red alga. Cancer Lett 167: 145-150.
18. Hornsey IS, Hide D (1976): The production of antimicrobial compounds by British marine algae. II. Seasonal variation in production of antibiotics. British Phycol J 11: 63-67.
19. Huang K, Wang B (2004): Antioxidant capacity and lipophilic content of seaweeds collected from the Qingdao coastline. J Agric Food Chem 52: 4993-4997.
20. Huheihel M, Ishanu V, Tal J, Arad S (2002): Activity of Porphyridium sp. polysaccharide against Herpes simplex viruses in vitro and in vivo. J Biochem Biophys Methods 50: 189-200.
21. Jiang Z, Jensen PR, Fenical W (1999): Lobophorins A and B, new antiinflammatory macrolides produced by a tropical marine bacterium. Bioorg Med Chem Lett 9: 2003-2006.
22. Johns RB, Nichols PD, Perry GJ (1979): Fatty acid composition of ten marine algae from Australian waters. Phytochemistry 18: 799-802.
23. Kakita H, Fukuoka S, Obika H, Kamishima H (1999): Isolation and characterisation of a fourth hemagglutinin from the red alga, Gracilaria verrucosa, from Japan. J Appl Phycol 11: 49-56.
24. Kaufmann SHE (2000): Is the development of a new tuberculosis vaccine possible? Nat Med 6: 955-960.
25. Kim JH, Hudson JB, Huang AM, Bannister K, Jin H, Choi TJ, Towers GHN, Hong YK, De Wreede RE (1997): Biological activities of seaweed extracts from British Columbia, Canada, and Korea. I. Antiviral activity. Can J Bot 75: 1656-1660.
26. Kondo E, Kanai K (1972): Lethal effect of long-chain fatty acids on mycobacteria. Jpn J Med Sci Biol 25: 1-13.
27. König GM, Wright AD, Franzblau SG (2000): Assessment of antimycobacterial activity of a series of mainly marine derived natural products. Planta Med 66: 337-342.
28. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H (2003): Oversulfation of fucoidan enhances its antiangiogenic and antitumor activities. Biochem Pharmacol 65: 173-179.
29. Lall N, Meyer JJM (1999): In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. J Ethnopharmacol 66: 347-354.
30. Moulari B, Pellequer Y, Lboutounne H, Girard C, Chaumont JP, Millet J, Muyard F (2006): Isolation and in vitro antibacterial activity of astilbin, the bioactive flavanone from the leaves of Harungana madagascariensis Lam. ex Poir. (Hypericaceae). J Ethnopharmacol 106: 272-278.
31. O'Brien RJ (2001): Tuberculosis: Scientific Blueprint for Tuberculosis Drug Development. Global Alliance for TB Drug Development, New York, Churchill Livingstone, P. 3.
32. Ohta S, Chang T, Kawashima A, Aozasa O, Mase Y, Nagate T, Kitamura K, Kondo M, Miyata H (1993): Antibiotic activity of unsaturated fatty acids on methicillin-resistant Staphylococcus aureus. Biosci Biotechnol Biochem 57: 2194-2195.
33. Okai Y, Higashi-Okai K (1997): Potent anti-inflammatory activity of pheophytin A derived from edible green alga, Enteromorpha prolifera (Sujiao-nori). Int J Immunopharmacol 19: 355-358.
34. Pettitt TR, Jones AL, Harwood JL (1989): Lipids of the marine red algae, Chondrus crispus and Polysiphonia lanosa. Phytochemistry 28: 399-405.
35. Raviglione MC (2002): The TB epidemic from 1992 to 2002. Tuberculosis 83: 4-14.
36. Sanina NM, Goncharova SN, Kostetsky EY (2004): Fatty acid composition of individual polar lipid classes from marine macrophytes. Phytochemistry 65: 721-730.
37. Seidel V, Taylor PW (2004): In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria. Int J Antimicrob Agents 23: 613-619.
38. Shan BE, Yoshida Y, Kuroda U, Yamashita U (1999): Immunomodulating actvity of seaweed extract on human lymphocytes in vitro. Int J Immunopharmacol 21: 59-70.
39. Siddiqi SH (1995): Bactec 460 TB System. Product and Procedure Manual, revision D. Becton Dickinson Diagnostic System, Sparks, MD.
40. Stavri M, Schneider R, O'Donnell G, Lechner D, Bucar F, Gibbons S (2004): The antimycobacterial components of hops (Humulus lupulus) and their dereplication. Phytother Res 18: 774-776.
41. Stegenga H, Bolton JJ, Anderson RJ (1997): Seaweeds of the South African West Coast. Cape Town, Contributions from the Bolus Herbarium, Number 18, pp. 8, 554.
42. Stirk WA, Jäger AK, Van Staden J (1996): Screening of some South African seaweeds for prostaglandin-synthesis inhibitors. South African J Bot 62: 108-110.
43. Stirk WA, Van Staden J (1997): Screening of some South African seaweeds for cytokinin-like activity. South African J Bot 63: 161-164.
44. Suksamrarn A, Buaprom M, Udtip S, Nuntawong N, Haritakun R, Kanokmedhakul S (2005): Antimycobacterial and antiplasmodial unsaturated carboxylic acid from the twigs of Scleropyrum wallichianum. Chem Pharm Bull 53: 1327-1329.
45. Vlachos V, Critchley AT, Von Holy A (1997): Antimicrobial activity of extracts from selected southern African marine macroalgae. South African J Sci 93: 328-332.
46. World Health Report (2004). Global tuberculosis control: surveillance planning, financing. Available at URL: http://www.who.int/tb/publications/global report/en/
47. Zhang Q, Li N, Liu X, Zhao Z, Li Z, Xu Z (2004): The structure of a sulfated galactan from Porphyra haitanensis and its in vivo antioxidant activity. Carbohydr Res 339: 105-111.
48. Zhou G, Sun YP, Xin H, Zhang Y, Li Z, Xu Z (2004): In vivo antitumor and immunomodulating activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol Res 50: 47-53.